Cibus

01/31/2024

Politicians, scientists, and farmers in Africa and around the world are getting behind the promise of new genomic techniques to transform for a more productive, resilient, and sustainable future. In the coming weeks, Europe faces a critical opportunity to join the global movement to build a whole new value chain behind this technology, writes Anjana Ahuja in an opinion piece for the Financial Times: https://on.ft.com/3OrSGfD

Scientists in Africa and elsewhere are seizing the opportunity to transform agriculture

01/26/2024

Wednesday was a key step towards making European agriculture more productive, resilient, and sustainable. Cibus applauds the Environment Committee of the European Parliament's vote in favour of the new legislation for New Genomic Techniques (NGTs). Read more: https://ow.ly/9LtT50QuFrN

01/17/2024

In the trait business, ongoing successful field trials are key elements of all commercial programs. Cibus had a successful field season for each of our 3 developed traits — HT1 and HT3 rice herbicide tolerance traits, and canola Pod Shatter Reduction (PSR) trait — in 2023.

Learn more: https://investor.cibus.com/news-releases/news-release-details/cibus-2023-field-trial-results-move-developed-traits-closer

01/04/2024

Cibus has agreed to partner with Interoc to provide traits for their elite rice seed genetics, starting with our rice herbicide tolerance traits. This collaboration agreement is an important step in launching our breakthrough-developed rice traits for w**d management in South America, a large and important rice market.

More on this exciting agreement: https://investor.cibus.com/news-releases/news-release-details/cibus-enters-latin-america-collaboration-agreement-interoc

12/29/2023

This past year has been transformative for Cibus. A few highlights:

- Calyxt and Cibus Merge

- $20.3 Million Registered Direct Offering

- Cibus opens a dedicated, high-throughput gene editing facility for trait production

- Two Cibus case studies in The International Journal of Plant Biology

- Greenhouse test results demonstrate successful resistance against White Mold (Sclerotinia) in canola

We would like to thank all who contributed to our success in 2023 and look forward to working together in 2024!

12/14/2023

Earlier this week, we announced a $20.3 million registered direct offering priced at-the-market under Nasdaq rules. Cibus intends to use the net proceeds from this offering to fund further development of new and existing seed traits, including Canola and Rice, Trait Machine maintenance, research and development and working capital and general corporate purposes.

The offering is expected to close on December 14, 2023, subject to the satisfaction of customary closing conditions.

Please read our release for full details: https://investor.cibus.com/news-releases/news-release-details/cibus-announces-203-million-registered-direct-offering

11/13/2023

In last week's , Cibus management shared details about the completed field trials for our three developed traits--pod shatter reduction in canola and HT1 and HT3 in rice--and progress toward their commercialization. Plus, continued development of our high-throughput soybean editing system, initial UK field trials, and specifics on our recent strategic realignment. Listen to the webcast replay here: https://investor.cibus.com/events/event-details/cibus-3q23-financial-results-conference-call

$CBUS

11/09/2023

Today, Cibus will issue its Q3 after the market closes.

Join Cibus' management team at 4:30 PM ET for a live conference call where we will discuss our financial results and other company updates. The call can be accessed by dialing (877) 243-8548, or for international callers by dialing (312) 281-2974. A live audio webcast of the call is also available on our investor relations website at: https://investor.cibus.com/events/event-details/cibus-3q23-financial-results-conference-call

$CBUS

11/06/2023

We are pleased to see continued progress in the EU on their ambitious goals for the regulation of New Genomic Techniques (NGTs). These techniques, which Cibus has helped pioneer, have the ability to enhance agriculture by making crops more resilient and sustainable. Under the European Commission’s proposal, NGT products would be regulated similarly to their conventional counterparts, providing unprecedented opportunities for European agriculture and food production.

Read more at: https://investor.cibus.com/news-releases/news-release-details/european-parliament-releases-draft-report-proposal-regulation

10/16/2023

Water is a precious, finite resource. On this , we are reminded that water is life, water is food, and that what we eat and how that food is produced all affect water.

Cibus’ productivity traits are expected to reduce the application of agricultural chemicals, including fertilizer, on major row crops globally, protecting water quality from agricultural runoff: https://www.cibus.com/productivity-traits.php

Together, we can take water action for food and be the change.

Food and Agriculture Organization of the United Nations (FAO)

09/22/2023

A great story out of the BBC News showcases the potential of gene editing for improving the sustainability of agriculture and our global food supply. As Europe moves to approve gene editing, the potential to address sustainability in less time and with a lower cost than conventional breeding is at a critical point:

Researchers are tweaking the photosynthesis process to raise the output of crops like soy, maize and wheat.

09/19/2023

Cibus is proud to announce that Jim Collins has been elected to our Board of Directors.

The former CEO of Corteva Agriscience and COO of the Ag Division of its predecessor DowDuPont, Jim's strategic leadership and experience will help focus and advance our commercialization efforts as we begin initial trials.

Learn more about this exciting appointment: https://investor.cibus.com/news-releases/news-release-details/jim-collins-join-cibus-board-directors

Please join us in welcoming Jim to the Cibus team!